ReviewVeterinary microbiology2008
Control of Mycoplasma hyopneumoniae infections in pigs.
Review in Veterinary microbiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 154 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
154 citing papers in PubMed, 2 syntheses or guidelines pooled it, 419 citations in OpenAlex.
- Influence of vaccination against infectious diseases on the carbon footprint of fattening pigs: a systematic review.Frontiers in veterinary science · 2024Pooled it
- Pooled it
- Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains.BMC veterinary research · 2017Trial
- A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs.BMC veterinary research · 2017Trial
- Effect of challenge of pigs previously immunised with inactivated vaccines containing homologous and heterologous Mycoplasma hyopneumoniae strains.BMC veterinary research · 2012Trial
- Occurrence, Severity and Temporal Trends of Enzootic Pneumonia-like Lung Lesions in Hungarian Slaughter Pigs, 2018-2022: Insights from Zero-Inflated Mixed-Effects Models.Animals : an open access journal from MDPI · 2026Article
- Veterinary antimicrobials practices for swine mycoplasmoses: a field survey and comparison with scientific and regulatory recommendations.Porcine health management · 2026Article
- Evaluation of alternative antimicrobial strategies in high-performance pigs for managing endemic Mycoplasma hyopneumoniae populations.Tropical animal health and production · 2026Article
- Comparative Safety and Efficacy of Commercial Porcine Vaccines AgainstAnimals : an open access journal from MDPI · 2026Article
- Article
- A RNase H2-Linked TaqMan-MGB Quantitative Real-Time PCR Assay for Differential Detection ofTransboundary and emerging diseases · 2026Article
- Efficacy and Safety Evaluation of a Ready-to-Use Bivalent Porcine Circovirus Type 2 andVaccines · 2025Article
- Efficacy of genetically modified Mycoplasma hyopneumoniae strains and their effect on local and cell-mediated immune responses in pigs.Veterinary research · 2025Article
- Challenges and Opportunities of Bacterial Vaccines as Alternatives to Antimicrobials in Swine Health Management: Insights from U.S. Veterinarians.Pathogens (Basel, Switzerland) · 2025Article
- Comparative Efficacy of Horse and Chicken Serum for the In Vitro Cultivation ofPathogens (Basel, Switzerland) · 2025Article
- Prevalence and Risk Factors of Mycoplasma Hyopneumoniae in Swine Farms, Mainland China, 2003-2024: A Meta-Analysis.Veterinary sciences · 2025Article
- Machine Learning-Based Detection of Pig Coughs and Their Association with Respiratory Diseases in Fattening Pigs.Veterinary sciences · 2025Article
- Review
- Article
- A novel intradermal combination vaccine for PCV2 and Mycoplasma hyopneumoniae protection in swine: its use with Lawsonia intracellularis and PRRSV vaccines.Porcine health management · 2025Article
94 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mycoplasma hyopneumoniae, the primary pathogen of enzootic pneumonia, occurs worldwide and causes major economic losses to the pig industry. The organism adheres to and damages the ciliated epithelium of the respiratory tract. Affected pigs show chronic coughing, are more susceptible to other respiratory infections and have a reduced performance. Control of the disease can be accomplished in a number of ways. First, management practices and housing conditions in the herd should be optimized. These include all-in/all-out production, limiting factors that may destabilize herd immunity, maintaining optimal stocking densities, prevention of other respiratory diseases, and optimal housing and climatic conditions. Strategic medication with antimicrobials active against M. hyopneumoniae and, preferably, also against major secondary bacteria may be useful during periods when the pigs are at risk for respiratory disease. Finally, commercial bacterins are widely used to control M. hyopneumoniae infections. The main effects of vaccination include less clinical symptoms, lung lesions and medication use, and improved performance. However, bacterins provide only partial protection and do not prevent colonization of the organism. Different vaccination strategies (timing of vaccination, vaccination of sows, vaccination combined with antimicrobial medication) can be used, depending on the type of herd, the production system and management practices, the infection pattern and the preferences of the pig producer. Research on new vaccines is actively occurring, including aerosol and feed-based vaccines as well as subunit and DNA vaccines. Eradication of the infection at herd level based on age-segregation and medication is possible, but there is a permanent risk for re-infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.